vs

Side-by-side financial comparison of BLACKLINE, INC. (BL) and Core Laboratories Inc. (CLB). Click either name above to swap in a different company.

BLACKLINE, INC. is the larger business by last-quarter revenue ($183.2M vs $138.3M, roughly 1.3× Core Laboratories Inc.). Core Laboratories Inc. runs the higher net margin — 5.3% vs 2.7%, a 2.6% gap on every dollar of revenue. On growth, BLACKLINE, INC. posted the faster year-over-year revenue change (8.1% vs 2.8%). BLACKLINE, INC. produced more free cash flow last quarter ($26.1M vs $5.1M). Over the past eight quarters, BLACKLINE, INC.'s revenue compounded faster (7.9% CAGR vs 2.9%).

BlackLine Systems, Inc., is an American enterprise software company that develops cloud-based services designed to automate and manage the entire financial close process as well as consolidation, invoice-to-cash, and intercompany accounting. The Los Angeles–based company has 17 offices worldwide.

Abbott Laboratories, commonly known as Abbott, is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois. The company produces pharmaceuticals for sale outside the United States, diagnostic products, nutritional products, and medical devices.

BL vs CLB — Head-to-Head

Bigger by revenue
BL
BL
1.3× larger
BL
$183.2M
$138.3M
CLB
Growing faster (revenue YoY)
BL
BL
+5.3% gap
BL
8.1%
2.8%
CLB
Higher net margin
CLB
CLB
2.6% more per $
CLB
5.3%
2.7%
BL
More free cash flow
BL
BL
$20.9M more FCF
BL
$26.1M
$5.1M
CLB
Faster 2-yr revenue CAGR
BL
BL
Annualised
BL
7.9%
2.9%
CLB

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
BL
BL
CLB
CLB
Revenue
$183.2M
$138.3M
Net Profit
$4.9M
$7.3M
Gross Margin
75.2%
Operating Margin
3.7%
11.5%
Net Margin
2.7%
5.3%
Revenue YoY
8.1%
2.8%
Net Profit YoY
-91.3%
1.2%
EPS (diluted)
$0.07
$0.16

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BL
BL
CLB
CLB
Q1 26
$138.3M
Q4 25
$183.2M
$138.3M
Q3 25
$178.3M
$134.5M
Q2 25
$172.0M
$130.2M
Q1 25
$166.9M
$123.6M
Q4 24
$169.5M
$129.2M
Q3 24
$165.9M
$134.4M
Q2 24
$160.5M
$130.6M
Net Profit
BL
BL
CLB
CLB
Q1 26
$7.3M
Q4 25
$4.9M
$4.9M
Q3 25
$5.3M
$14.2M
Q2 25
$8.3M
$10.6M
Q1 25
$6.1M
$-154.0K
Q4 24
$56.4M
$7.4M
Q3 24
$17.2M
$11.7M
Q2 24
$76.7M
$9.0M
Gross Margin
BL
BL
CLB
CLB
Q1 26
Q4 25
75.2%
20.8%
Q3 25
75.1%
22.0%
Q2 25
75.2%
20.3%
Q1 25
75.5%
19.5%
Q4 24
75.6%
17.8%
Q3 24
75.2%
20.5%
Q2 24
74.9%
21.2%
Operating Margin
BL
BL
CLB
CLB
Q1 26
11.5%
Q4 25
3.7%
11.5%
Q3 25
4.3%
15.6%
Q2 25
4.4%
11.7%
Q1 25
2.1%
3.6%
Q4 24
3.7%
11.0%
Q3 24
5.0%
14.7%
Q2 24
1.4%
12.3%
Net Margin
BL
BL
CLB
CLB
Q1 26
5.3%
Q4 25
2.7%
3.6%
Q3 25
3.0%
10.6%
Q2 25
4.8%
8.2%
Q1 25
3.6%
-0.1%
Q4 24
33.3%
5.7%
Q3 24
10.4%
8.7%
Q2 24
47.8%
6.9%
EPS (diluted)
BL
BL
CLB
CLB
Q1 26
$0.16
Q4 25
$0.07
$0.11
Q3 25
$0.09
$0.30
Q2 25
$0.13
$0.22
Q1 25
$0.10
$0.00
Q4 24
$0.79
$0.15
Q3 24
$0.27
$0.25
Q2 24
$0.22
$0.19

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BL
BL
CLB
CLB
Cash + ST InvestmentsLiquidity on hand
$390.0M
$22.8M
Total DebtLower is stronger
Stockholders' EquityBook value
$332.3M
$279.8M
Total Assets
$1.8B
$597.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BL
BL
CLB
CLB
Q1 26
$22.8M
Q4 25
$390.0M
$22.7M
Q3 25
$419.9M
$25.6M
Q2 25
$459.1M
$31.2M
Q1 25
$479.5M
$22.1M
Q4 24
$885.9M
$19.2M
Q3 24
$725.3M
$21.5M
Q2 24
$616.6M
$17.7M
Total Debt
BL
BL
CLB
CLB
Q1 26
Q4 25
$110.3M
Q3 25
$114.1M
Q2 25
$124.6M
Q1 25
$124.4M
Q4 24
$126.1M
Q3 24
$139.9M
Q2 24
$147.6M
Stockholders' Equity
BL
BL
CLB
CLB
Q1 26
$279.8M
Q4 25
$332.3M
$266.0M
Q3 25
$328.3M
$271.3M
Q2 25
$414.0M
$261.3M
Q1 25
$417.9M
$253.4M
Q4 24
$446.7M
$246.6M
Q3 24
$367.9M
$250.7M
Q2 24
$325.8M
$240.3M
Total Assets
BL
BL
CLB
CLB
Q1 26
$597.0M
Q4 25
$1.8B
$584.0M
Q3 25
$1.7B
$591.4M
Q2 25
$1.8B
$602.1M
Q1 25
$1.8B
$591.5M
Q4 24
$1.8B
$585.1M
Q3 24
$1.7B
$600.5M
Q2 24
$1.9B
$597.8M
Debt / Equity
BL
BL
CLB
CLB
Q1 26
Q4 25
0.41×
Q3 25
0.42×
Q2 25
0.48×
Q1 25
0.49×
Q4 24
0.51×
Q3 24
0.56×
Q2 24
0.61×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BL
BL
CLB
CLB
Operating Cash FlowLast quarter
$26.7M
$37.2M
Free Cash FlowOCF − Capex
$26.1M
$5.1M
FCF MarginFCF / Revenue
14.2%
3.7%
Capex IntensityCapex / Revenue
0.3%
Cash ConversionOCF / Net Profit
5.46×
5.12×
TTM Free Cash FlowTrailing 4 quarters
$161.5M
$27.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BL
BL
CLB
CLB
Q1 26
$37.2M
Q4 25
$26.7M
$7.9M
Q3 25
$63.8M
$8.5M
Q2 25
$32.3M
$13.9M
Q1 25
$46.7M
$6.7M
Q4 24
$43.8M
$20.6M
Q3 24
$55.9M
$13.1M
Q2 24
$40.7M
$17.1M
Free Cash Flow
BL
BL
CLB
CLB
Q1 26
$5.1M
Q4 25
$26.1M
$5.0M
Q3 25
$63.3M
$6.5M
Q2 25
$31.4M
$10.4M
Q1 25
$40.8M
$3.9M
Q4 24
$43.0M
$17.4M
Q3 24
$55.5M
$10.4M
Q2 24
$40.0M
$14.3M
FCF Margin
BL
BL
CLB
CLB
Q1 26
3.7%
Q4 25
14.2%
3.6%
Q3 25
35.5%
4.8%
Q2 25
18.2%
8.0%
Q1 25
24.4%
3.1%
Q4 24
25.4%
13.4%
Q3 24
33.5%
7.7%
Q2 24
24.9%
10.9%
Capex Intensity
BL
BL
CLB
CLB
Q1 26
Q4 25
0.3%
2.1%
Q3 25
0.3%
1.5%
Q2 25
0.6%
2.7%
Q1 25
3.6%
2.3%
Q4 24
0.4%
2.5%
Q3 24
0.2%
2.0%
Q2 24
0.4%
2.2%
Cash Conversion
BL
BL
CLB
CLB
Q1 26
5.12×
Q4 25
5.46×
1.61×
Q3 25
12.07×
0.60×
Q2 25
3.90×
1.31×
Q1 25
7.72×
Q4 24
0.78×
2.78×
Q3 24
3.24×
1.12×
Q2 24
0.53×
1.90×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BL
BL

Subscription And Circulation$173.2M95%
Technology Service$10.0M5%

CLB
CLB

Segment breakdown not available.

Related Comparisons